Bill Information > HB 1224
Search for another bill or initiative:
HB 1224 - 2019-20
Concerning prescription drug cost transparency.
See Bill History for complete details on the bill
Substitute - SHB 1224
Where is it in the process?
2019 REGULAR SESSION
First reading, referred to Health Care & Wellness. (View Original Bill)
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
Executive action taken in the House Committee on Health Care & Wellness at 8:00 AM. (Committee Materials)
Minority; do not pass. (Minority Report)
Minority; without recommendation. (Minority Report)
Referred to Appropriations.
For a complete list of documents, go to Online Reports Text of a Legislative Document.